Novartis AG Says Acquisition Of Avidity Valued At $12 Billion

Oct 26 (Reuters) - Novartis AG NOVN.S:

• NOVARTIS AGREES TO ACQUIRE AVIDITY BIOSCIENCES, AN INNOVATOR IN RNA THERAPEUTICS, STRENGTHENING ITS LATE-STAGE NEUROSCIENCE PIPELINE

• NOVARTIS AG - ACQUISITION OF AVIDITY VALUED AT $12 BILLION

• NOVARTIS AG - AVIDITY STOCKHOLDERS TO RECEIVE $72 PER SHARE, 46% PREMIUM

• NOVARTIS AG - RAISES EXPECTED SALES CAGR TO 6% FOR 2024-2029

• NOVARTIS AG -AVIDITY WILL SEPARATE ITS EARLY-STAGE PRECISION CARDIOLOGY PROGRAMS INTO A NEW COMPANY ("SPINCO") PRIOR TO CLOSING

• NOVARTIS AG -NOVARTIS AG - ACQUISITION OF AVIDITY VALUED AT $12 BILLION